<SEC-DOCUMENT>0001485003-19-000096-index.html : 20191129 <SEC-HEADER>0001485003-19-000096.hdr.sgml : 20191129 <ACCEPTANCE-DATETIME>20191129085154 ACCESSION NUMBER: 0001485003-19-000096 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20191129 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191129 DATE AS OF CHANGE: 20191129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 191259882 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>sesn-form8xk2019atmv112520.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: sesn-form8xk2019atmv112520.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>sesn-exhibit5opinionnovemb.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: sesn-exhibit5opinionnovemb.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>sesn-atmsalesagencyagreeme.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 3 - file: sesn-atmsalesagencyagreeme.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>sesnexhibit5opinion.jpg <TEXT> Document 4 - file: sesnexhibit5opinion.jpg
</DOCUMENT> </SEC-DOCUMENT>